Assessing Response to Treatment in Non-Hodgkin's Lymphoma Patients Using 64Cu-DOTA-Rituximab PET/CT

This study has been withdrawn prior to enrollment.
(Accrual issues - Low Accrual)
Sponsor:
Information provided by (Responsible Party):
Sanjiv Sam Gambhir, Stanford University
ClinicalTrials.gov Identifier:
NCT01598558
First received: February 10, 2012
Last updated: November 16, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)